DV Trading’s Oruka Therapeutics ORKA Stock Holding History

DV Trading’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-492	Closed	-$14.9K	–	1253
2025 Q4	$14.9K	Buy	+492	New	+$13.7K	﹤0.01%	704

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DV Trading's ORKA Position: Q1 2026 in Review

DV Trading sold out of Oruka Therapeutics (ORKA) in Q1 2026, closing a stake of 492 shares — an estimated $14.9K sold.

DV Trading first reported a position in ORKA in Q4 2025 and held it in 1 quarter. The position peaked at $14.9K in Q4 2025. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

DV Trading reported no remaining Oruka Therapeutics position as of Q1 2026 after selling out during the quarter.
DV Trading sold 492 Oruka Therapeutics shares in Q1 2026, an estimated $14.9K.
DV Trading first reported a position in Oruka Therapeutics in Q4 2025 and held it in 1 quarter.
DV Trading's Oruka Therapeutics position peaked at $14.9K in Q4 2025.
184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on DV Trading's 13F filing for Q1 2026, filed 15 May 2026.